Two Sigma Investments, LP Agios Pharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$21.32 - $34.81 $1.63 Million - $2.66 Million	76,359 Added 166.28%	122,282 $3.58 Million
Q4 2023 Feb 14, 2024	BUY	$19.97 - $24.53 $917,082 - $1.13 Million	45,923 New	45,923 $1.02 Million
Q4 2020 Feb 16, 2021	SELL	$33.21 - $46.54 $2.02 Million - $2.84 Million	-60,954 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$33.87 - $55.93 $2.06 Million - $3.41 Million	60,954 New	60,954 $2.13 Million
Q4 2019 Feb 14, 2020	SELL	$30.08 - $50.59 $3.41 Million - $5.73 Million	-113,306 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$32.4 - $49.58 $1.81 Million - $2.77 Million	55,866 Added 97.26%	113,306 $3.67 Million
Q2 2019 Aug 14, 2019	BUY	$46.17 - $68.1 $2.65 Million - $3.91 Million	57,440 New	57,440 $2.87 Million
Q1 2019 May 15, 2019	SELL	$45.92 - $67.67 $10.6 Million - $15.6 Million	-230,710 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$42.73 - $76.53 $6.53 Million - $11.7 Million	152,792 Added 196.09%	230,710 $10.6 Million
Q3 2018 Nov 14, 2018	BUY	$71.67 - $91.95 $5.58 Million - $7.16 Million	77,918 New	77,918 $6.01 Million
Q2 2018 Aug 14, 2018	SELL	$73.22 - $99.55 $9.94 Million - $13.5 Million	-135,807 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$59.83 - $86.53 $4.94 Million - $7.14 Million	82,542 Added 154.96%	135,807 $11.1 Million
Q4 2017 Feb 14, 2018	BUY	$52.12 - $72.33 $283,220 - $393,041	5,434 Added 11.36%	53,265 $3.05 Million
Q3 2017 Nov 14, 2017	BUY	$54.89 - $67.12 $2.63 Million - $3.21 Million	47,831	47,831 $3.19 Million

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.24B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.